A Study of Docetaxel for Injection (Albumin-bound) in Combination With Nivolumab in Patients With Head and Neck (SCCHN)
Clinical trial NCT05027204 · UNKNOWN
Trial details
- NCT number
- NCT05027204
- Sponsor
- CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-03-04
- Primary completion
- 2023-10-31
- Enrollment
- 94
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.